UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051117
Receipt number R000058300
Scientific Title A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy
Date of disclosure of the study information 2023/05/22
Last modified on 2023/05/21 13:08:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy

Acronym

A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy

Scientific Title

A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy

Scientific Title:Acronym

A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy

Region

Japan


Condition

Condition

early gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

After endoscopic treatment of early gastric cancer, proton pump inhibitors or vonoprazan are commonly used to suppress gastric acid secretion in order to form artificial gastric ulcers. However, there is no consensus on the appropriate duration of treatment, and gastric acid secretion inhibitors are usually taken for two months after endoscopic treatment. Recently, however, there have been reports of patients discontinuing vonoprazan after three weeks. However, there have been no studies of cases in which the area of dissection increases after endoscopic treatment of early gastric cancer. In this study, esophagogastroduodenoscopy will be performed three weeks after endoscopic treatment of early gastric cancer to confirm the healing status of ulcers after endoscopic treatment.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

esophagogastroduodenoscopy three weeks after endoscopic treatment to evaluate the size of post-endoscopic ulcer, evaluation of ulcer according to the Sakita-Miwa classification.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Endoscopic treatment indications

Key exclusion criteria

Patients over 90 years of age, patients unable to give consent, other patients considered inappropriate for treatment, and patients with contraindications to vonoprazan.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Suto

Organization

International University of Health and Welfare Hospital

Division name

Department of Gastroenterology

Zip code

329-2763

Address

537-3, Iguchi, Nasushiobara, Tochigi 329-2763, Japan

TEL

0287-39-3060

Email

daisuto@iuhw.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Suto

Organization

International University of Health and Welfare Hospital

Division name

Department of Gastroenterology

Zip code

329-2763

Address

537-3, Iguchi, Nasushiobara, Tochigi 329-2763, Japan

TEL

0287-39-3060

Homepage URL


Email

daisuto@iuhw.ac.jp


Sponsor or person

Institute

International University of Health and Welfare Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

International University of Health and Welfare Hospital

Address

537-3, Iguchi, Nasushiobara, Tochigi 329-2763, Japan

Tel

0287-39-3060

Email

daisuto@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 05 Month 22 Day

Date of IRB


Anticipated trial start date

2023 Year 05 Month 22 Day

Last follow-up date

2025 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

n this study, esophagogastroduodenoscopy will be performed three weeks after endoscopic treatment of early gastric cancer to confirm ulcer healing status after endoscopic treatment.


Management information

Registered date

2023 Year 05 Month 21 Day

Last modified on

2023 Year 05 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058300


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name